Literature DB >> 10662868

Treatment and investigation of idiopathic inflammatory myopathies.

I Lundberg1, Y Chung.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10662868     DOI： 10.1093/rheumatology/39.1.7

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  7 in total

1.  An unusual association: anti-Jo1 and anti-SRP antibodies in the serum of a patient with polymyositis.

Authors:  Melinda Vincze; Peter A Molnár; Judit Tumpek; Lászlóné Szollosi; Agnes Gyetvai; Anikó Kapitány; Katalin Dankó
Journal:  Clin Rheumatol       Date:  2010-03-12       Impact factor: 2.980

Review 2.  Clinical and radiological features of lung disorders related to connective-tissue diseases: a pictorial essay.

Authors:  Stefano Palmucci; Federica Galioto; Giulia Fazio; Agata Ferlito; Giovanna Cancemi; Alessia Di Mari; Gianluca Sambataro; Domenico Sambataro; Giovanni Zanframundo; Letizia Antonella Mauro; Pietro Valerio Foti; Carlo Vancheri; Antonio Basile
Journal:  Insights Imaging       Date:  2022-06-29

Review 3.  Nonimmune mechanisms of muscle damage in myositis: role of the endoplasmic reticulum stress response and autophagy in the disease pathogenesis.

Authors:  Andrea Henriques-Pons; Kanneboyina Nagaraju
Journal:  Curr Opin Rheumatol       Date:  2009-11       Impact factor: 5.006

Review 4.  Inflammatory Myopathies.

Authors:  Rama Bandlamudi Atluri
Journal:  Mo Med       Date:  2016 Mar-Apr

Review 5.  Trichinella inflammatory myopathy: host or parasite strategy?

Authors:  Fabrizo Bruschi; Lorena Chiumiento
Journal:  Parasit Vectors       Date:  2011-03-23       Impact factor: 3.876

6.  Hypercapnic respiratory failure during pregnancy due to polymyositis-related respiratory muscle weakness: a case report.

Authors:  Husain Shabbir Ali; Ibrahim Fawzy Hassan; Saibu George; Abdalrazig Elsadig Fadlelmula
Journal:  J Med Case Rep       Date:  2017-07-26

7.  Medical resource utilization in dermatomyositis/polymyositis patients treated with repository corticotropin injection, intravenous immunoglobulin, and/or rituximab.

Authors:  Tyler Knight; T Christopher Bond; Breanna Popelar; Li Wang; John W Niewoehner; Kathryn Anastassopoulos; Michael Philbin
Journal:  Clinicoecon Outcomes Res       Date:  2017-05-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.